Skip to main content
Erschienen in: Annals of Hematology 12/2016

19.08.2016 | Original Article

Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia

verfasst von: Eleshia J. Morrison, Joseph M. Flynn, Jeffrey Jones, John C. Byrd, Barbara L. Andersen

Erschienen in: Annals of Hematology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Chronic lymphocytic leukemia (CLL) is an incurable illness, with some patients requiring no treatment until disease progression. Burden from physical symptoms has been associated with depression, anxiety, and stress in cancer patients. Additionally, patient factors, i.e., individual differences, have been associated with worse psychological outcomes. There are few psychological studies of CLL, with no examination of individual differences. A cross-sectional design studied the covariation of symptom burden with depressive and anxiety symptoms and cancer-specific stress, and tested patients’ individual differences as predictors and as moderators. CLL patients (N = 112) receiving active surveillance participated. They were Caucasian (100 %) and predominately male (55 %) with a mean age of 61; most (62.5 %) had stage 0 disease. A composite measure of physical symptom burden (CLL symptoms, fatigue, pain, impaired functional status) was tested as a predictor of psychological responses. Individual differences in psychiatric history and social support were tested as moderators. Using multiple linear regression, greater symptom burden covaried with higher levels of depressive and anxiety symptoms and cancer stress (ps < .05). Those with a psychiatric history, low social support, and low relationship satisfaction with one’s partner reported greater symptom burden and more psychological symptoms and stress (ps < .05). Findings suggest that CLL patients in surveillance with a psychiatric history and/or low social support are at risk for greater distress when coping with high symptom burden. These new data clarify the experience of CLL surveillance and identify characteristics of patients with heightened risk for symptom burden, stress, and anxiety or depressive symptoms.
Literatur
1.
Zurück zum Zitat Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R (2004) Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr. Eur J Haematol 72:381–389CrossRefPubMed Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R (2004) Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr. Eur J Haematol 72:381–389CrossRefPubMed
2.
Zurück zum Zitat Singer C, Goldstone A (2001) Chronic lymphocytic leukaemia and other chronic lymphoid leukaemias. In: Souhami R, Tannock L, Hohenberger P, Horiot J-C (eds) Oxford textbook of oncology. Oxford University Press Inc., New York, pp 2254–2282 Singer C, Goldstone A (2001) Chronic lymphocytic leukaemia and other chronic lymphoid leukaemias. In: Souhami R, Tannock L, Hohenberger P, Horiot J-C (eds) Oxford textbook of oncology. Oxford University Press Inc., New York, pp 2254–2282
3.
Zurück zum Zitat Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:5446–5456CrossRefPubMedPubMedCentral Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:5446–5456CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Levin TT, Li Y, Riskind J, Rai K (2007) Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. Gen Hosp Psychiatry 29:251–256CrossRefPubMed Levin TT, Li Y, Riskind J, Rai K (2007) Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. Gen Hosp Psychiatry 29:251–256CrossRefPubMed
5.
Zurück zum Zitat Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440–447CrossRefPubMedPubMedCentral Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440–447CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Morrow GR, Roscoe JA, Hickok JT, Andrews PLR, Matteson S (2002) Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer 10:96–105CrossRefPubMed Morrow GR, Roscoe JA, Hickok JT, Andrews PLR, Matteson S (2002) Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer 10:96–105CrossRefPubMed
7.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors-a systematic review. Int J Psychiatry Med 40:163–181CrossRefPubMed Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors-a systematic review. Int J Psychiatry Med 40:163–181CrossRefPubMed
8.
Zurück zum Zitat Carpenter KM, Fowler JM, Maxwell GL, Anderson BL (2010) Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med 39:79–90CrossRefPubMedPubMedCentral Carpenter KM, Fowler JM, Maxwell GL, Anderson BL (2010) Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med 39:79–90CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Jim HS, Andrykowski MA, Munster PN, Jacobsen PB (2007) Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Ann Behav Med 34:200–208CrossRefPubMed Jim HS, Andrykowski MA, Munster PN, Jacobsen PB (2007) Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Ann Behav Med 34:200–208CrossRefPubMed
10.
Zurück zum Zitat Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O et al (2005) Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 23:3061–3068CrossRefPubMed Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O et al (2005) Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 23:3061–3068CrossRefPubMed
11.
Zurück zum Zitat Yang H-C, Brothers B, Andersen BL (2008) Stress and quality of life in breast cancer recurrence: moderation or mediation of coping? Ann Behav Med 35:188–197CrossRefPubMedPubMedCentral Yang H-C, Brothers B, Andersen BL (2008) Stress and quality of life in breast cancer recurrence: moderation or mediation of coping? Ann Behav Med 35:188–197CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Wettergren L, Langius A, Bjorkholm M, Bjorvell H (1999) Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncol 38:475–480CrossRefPubMed Wettergren L, Langius A, Bjorkholm M, Bjorvell H (1999) Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncol 38:475–480CrossRefPubMed
13.
Zurück zum Zitat Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE et al (2007) Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 139:255–264CrossRefPubMed Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE et al (2007) Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 139:255–264CrossRefPubMed
14.
Zurück zum Zitat Cheng KKF, Lee DTF (2011) Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol 78:127–137CrossRefPubMed Cheng KKF, Lee DTF (2011) Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol 78:127–137CrossRefPubMed
15.
Zurück zum Zitat Minton O, Stone P (2008) How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat 112:5–13CrossRefPubMed Minton O, Stone P (2008) How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat 112:5–13CrossRefPubMed
16.
Zurück zum Zitat Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 18:113–127CrossRefPubMedPubMedCentral Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 18:113–127CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jansen L, Koch L, Brenner H, Arndt V (2010) Quality of life among long-term (> = 5 years) colorectal cancer survivors—systematic review. Eur J Cancer 46:2879–2888CrossRefPubMed Jansen L, Koch L, Brenner H, Arndt V (2010) Quality of life among long-term (> = 5 years) colorectal cancer survivors—systematic review. Eur J Cancer 46:2879–2888CrossRefPubMed
18.
Zurück zum Zitat Dodd MJ, Cho MH, Cooper BA, Miaskowski C (2010) The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 14:101–110CrossRefPubMed Dodd MJ, Cho MH, Cooper BA, Miaskowski C (2010) The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 14:101–110CrossRefPubMed
19.
Zurück zum Zitat de Leeuw JRJ, de Graeff A, Ros WJG, Blijham GH, Hordijk G-H, Winnubst JAM (2000) Prediction of depressive symptomatology after treatment of head and neck cancer: The influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 22:799–807CrossRefPubMed de Leeuw JRJ, de Graeff A, Ros WJG, Blijham GH, Hordijk G-H, Winnubst JAM (2000) Prediction of depressive symptomatology after treatment of head and neck cancer: The influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 22:799–807CrossRefPubMed
20.
Zurück zum Zitat Harrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598CrossRefPubMed Harrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598CrossRefPubMed
21.
Zurück zum Zitat Morasso G, Costantini M, Viterbori P, Bonci F, Del Mastro L, Musso M et al (2001) Predicting mood disorders in breast cancer patients. Eur J Cancer 37:216–223CrossRefPubMed Morasso G, Costantini M, Viterbori P, Bonci F, Del Mastro L, Musso M et al (2001) Predicting mood disorders in breast cancer patients. Eur J Cancer 37:216–223CrossRefPubMed
22.
Zurück zum Zitat Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E et al (2006) Stem cell transplantation: risk factors for psychiatric morbidity. Eur J Cancer 42:514–520CrossRefPubMed Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E et al (2006) Stem cell transplantation: risk factors for psychiatric morbidity. Eur J Cancer 42:514–520CrossRefPubMed
23.
Zurück zum Zitat Pinquart M, Duberstein PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75:122–137CrossRefPubMed Pinquart M, Duberstein PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75:122–137CrossRefPubMed
24.
Zurück zum Zitat Sherman KA, Kasparian NA, Mireskandari S (2010) Psychological adjustment among male partners in response to women’s breast/ovarian cancer risk: a theoretical review of the literature. Psychooncology 19:1–11CrossRefPubMed Sherman KA, Kasparian NA, Mireskandari S (2010) Psychological adjustment among male partners in response to women’s breast/ovarian cancer risk: a theoretical review of the literature. Psychooncology 19:1–11CrossRefPubMed
25.
Zurück zum Zitat Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219–234PubMed Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219–234PubMed
26.
Zurück zum Zitat Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM et al (2011) Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D Anderson Symptom Inventory. Oncologist 16:217–227CrossRefPubMedPubMedCentral Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM et al (2011) Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D Anderson Symptom Inventory. Oncologist 16:217–227CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ et al (2010) Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116:2053–2063CrossRefPubMed Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ et al (2010) Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116:2053–2063CrossRefPubMed
28.
Zurück zum Zitat Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA et al (2013) Recommendations for including multiple symptoms as endpoints in cancer clinical trials. Cancer 119:411–420CrossRefPubMed Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA et al (2013) Recommendations for including multiple symptoms as endpoints in cancer clinical trials. Cancer 119:411–420CrossRefPubMed
30.
Zurück zum Zitat Cleeland C, Ryan K (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed Cleeland C, Ryan K (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed
31.
Zurück zum Zitat Hann DM, Jacobsen PB, Azzarello LM, Martin SC, Curran SL, Fields KK et al (1998) Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7:301–310CrossRefPubMed Hann DM, Jacobsen PB, Azzarello LM, Martin SC, Curran SL, Fields KK et al (1998) Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7:301–310CrossRefPubMed
32.
Zurück zum Zitat Hann DM, Denniston MM, Baker F (2000) Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 9:847–854CrossRefPubMed Hann DM, Denniston MM, Baker F (2000) Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 9:847–854CrossRefPubMed
33.
Zurück zum Zitat Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 199–205 Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 199–205
34.
Zurück zum Zitat Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
35.
Zurück zum Zitat Devins GM, Orme CM, Costello CG, Binik YM, Frizzell B, Stam HJ, Pullin WM (1988) Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health 2(2):139–156CrossRef Devins GM, Orme CM, Costello CG, Binik YM, Frizzell B, Stam HJ, Pullin WM (1988) Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health 2(2):139–156CrossRef
36.
Zurück zum Zitat Newman MG, Zuellig AR, Kachin KE, Constantino MJ, Przeworski A, Erickson T et al (2002) Preliminary reliability and validity of the generalized anxiety disorder questionnaire-IV: a revised self-report diagnostic measure of generalized anxiety disorder. Behav Ther 33:215–233CrossRef Newman MG, Zuellig AR, Kachin KE, Constantino MJ, Przeworski A, Erickson T et al (2002) Preliminary reliability and validity of the generalized anxiety disorder questionnaire-IV: a revised self-report diagnostic measure of generalized anxiety disorder. Behav Ther 33:215–233CrossRef
37.
Zurück zum Zitat Luterek JA, Turk CL, Heimburg RG, Fresco DM, Mennin DS (2002) Psychometric properties of the GAD-Q-IV among individuals with clinician-assessed generalized anxiety disorder: an update. Presented at the association for advancement of behavior therapy Luterek JA, Turk CL, Heimburg RG, Fresco DM, Mennin DS (2002) Psychometric properties of the GAD-Q-IV among individuals with clinician-assessed generalized anxiety disorder: an update. Presented at the association for advancement of behavior therapy
38.
Zurück zum Zitat Weiss DS, Marmar CR (1997) The impact of event scale—revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford Press, New York, pp 399–411 Weiss DS, Marmar CR (1997) The impact of event scale—revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford Press, New York, pp 399–411
39.
Zurück zum Zitat Shapinsky AC, Rapport LJ, Henderson MJ, Axelrod BN (2005) Civilian PTSD scales: relationships with trait characteristics and everyday distress. Assessment 12:220–230CrossRefPubMed Shapinsky AC, Rapport LJ, Henderson MJ, Axelrod BN (2005) Civilian PTSD scales: relationships with trait characteristics and everyday distress. Assessment 12:220–230CrossRefPubMed
40.
Zurück zum Zitat Cohen S, Mermelstein R, Kamarck T, Hoberman HM (1985) Measuring the functional components of social support. In: Sarason IG, Sarason BR (eds) Social support: theory, research and applications. Martinus Nijhoff Publishers, Dordrecht, pp 73–94CrossRef Cohen S, Mermelstein R, Kamarck T, Hoberman HM (1985) Measuring the functional components of social support. In: Sarason IG, Sarason BR (eds) Social support: theory, research and applications. Martinus Nijhoff Publishers, Dordrecht, pp 73–94CrossRef
41.
Zurück zum Zitat Spanier G (1976) Measuring dyadic adjustment: new scales assessing the quality of marriage and similar dyads. J Marriage Fam 38:15–28CrossRef Spanier G (1976) Measuring dyadic adjustment: new scales assessing the quality of marriage and similar dyads. J Marriage Fam 38:15–28CrossRef
42.
Zurück zum Zitat Goodwin R (1992) Overall, just how happy are you? The magical question 31 of the Spanier Dyadic Adjustment Scale. Fam Ther 19:273–275 Goodwin R (1992) Overall, just how happy are you? The magical question 31 of the Spanier Dyadic Adjustment Scale. Fam Ther 19:273–275
43.
Zurück zum Zitat IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp
44.
Zurück zum Zitat Tan G, Jensen MP, Thornby JI, Shanti BF (2004) Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 5(2):133–137CrossRefPubMed Tan G, Jensen MP, Thornby JI, Shanti BF (2004) Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 5(2):133–137CrossRefPubMed
45.
Zurück zum Zitat Andersen BL, Shapiro CL, Farrar WB, Crespin TR, Wells-DiGregorio S (2005) Psychological responses to cancer recurrence: a controlled prospective study. Cancer 104:1540–1547CrossRefPubMedPubMedCentral Andersen BL, Shapiro CL, Farrar WB, Crespin TR, Wells-DiGregorio S (2005) Psychological responses to cancer recurrence: a controlled prospective study. Cancer 104:1540–1547CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Creamer M, Bell R, Failla S (2003) Psychometric properties of the impact of event scale-revised. Behav Res Ther 41:1489–1496CrossRefPubMed Creamer M, Bell R, Failla S (2003) Psychometric properties of the impact of event scale-revised. Behav Res Ther 41:1489–1496CrossRefPubMed
47.
Zurück zum Zitat Lewinsohn PM, Seeley JR, Roberts RE, Allen NB (1997) Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging 12(2):277–287CrossRefPubMed Lewinsohn PM, Seeley JR, Roberts RE, Allen NB (1997) Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging 12(2):277–287CrossRefPubMed
48.
Zurück zum Zitat Robinson CM, Klenck SC, Norton PJ (2010) Psychometric properties of the generalized anxiety disorder questionnaire for DSM-IV among four racial groups. Cpgn Behav Ther 39(4):251–261CrossRef Robinson CM, Klenck SC, Norton PJ (2010) Psychometric properties of the generalized anxiety disorder questionnaire for DSM-IV among four racial groups. Cpgn Behav Ther 39(4):251–261CrossRef
49.
Zurück zum Zitat Yang HC, Schuler TA (2009) Marital quality and survivorship: slowed recovery for breast cancer patients in distressed relationships. Cancer 115:217–228CrossRefPubMedPubMedCentral Yang HC, Schuler TA (2009) Marital quality and survivorship: slowed recovery for breast cancer patients in distressed relationships. Cancer 115:217–228CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 289:3095–3105CrossRef Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 289:3095–3105CrossRef
51.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602CrossRefPubMed Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602CrossRefPubMed
52.
Zurück zum Zitat Andersen BL, DeRubeis RJ, Berman BS et al (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32(15):1605–1619CrossRefPubMedPubMedCentral Andersen BL, DeRubeis RJ, Berman BS et al (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32(15):1605–1619CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Kroenke K, Spitzer RL, Williams JB. (2001). The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 16: 606-613 Kroenke K, Spitzer RL, Williams JB. (2001). The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 16: 606-613
54.
Zurück zum Zitat Burton CL, Galatzer-Levy IR, Bonanno GA (2015) Treatment type and demographic characteristics as predictors for cancer adjustment: prospective trajectories of depressive symptoms in a population sample. Health Psychol 34:602–609CrossRefPubMed Burton CL, Galatzer-Levy IR, Bonanno GA (2015) Treatment type and demographic characteristics as predictors for cancer adjustment: prospective trajectories of depressive symptoms in a population sample. Health Psychol 34:602–609CrossRefPubMed
55.
Zurück zum Zitat Eichhorst B, Goede V, Hallek M (2009) Treatment of elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma 50(2):171–178CrossRefPubMed Eichhorst B, Goede V, Hallek M (2009) Treatment of elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma 50(2):171–178CrossRefPubMed
56.
Zurück zum Zitat de Wreede LC, Watson M, van Os M, Milligan D, van Gelder M, Michallet M et al (2014) Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study. Am J Hematol 89(2):174–180CrossRefPubMed de Wreede LC, Watson M, van Os M, Milligan D, van Gelder M, Michallet M et al (2014) Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study. Am J Hematol 89(2):174–180CrossRefPubMed
57.
Zurück zum Zitat Else M, Smith AG, Cocks K, Richards SM, Crofts S, Wade R, Catovsky D (2008) Patients’ experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. Br J Haematol 143(5):690–697CrossRefPubMed Else M, Smith AG, Cocks K, Richards SM, Crofts S, Wade R, Catovsky D (2008) Patients’ experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. Br J Haematol 143(5):690–697CrossRefPubMed
58.
Zurück zum Zitat Eichhorst BF, Busch R, Obwandner T, Kuhn-Hallek I, Herschbach P, Hallek M (2007) Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. J Clin Oncol 25(13):1722–1731CrossRefPubMed Eichhorst BF, Busch R, Obwandner T, Kuhn-Hallek I, Herschbach P, Hallek M (2007) Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. J Clin Oncol 25(13):1722–1731CrossRefPubMed
59.
Zurück zum Zitat Holzner B, Kemmler G, Sperner-Unterweger B, Kopp M, Dunser M, Margreiter R et al (2001) Quality of life measurement in oncology—a matter of the assessment instrument? Eur J Cancer 37(18):2349–2356CrossRefPubMed Holzner B, Kemmler G, Sperner-Unterweger B, Kopp M, Dunser M, Margreiter R et al (2001) Quality of life measurement in oncology—a matter of the assessment instrument? Eur J Cancer 37(18):2349–2356CrossRefPubMed
60.
Zurück zum Zitat van den Broek EC, Oerlemans S, Nijziel MR, Posthuma EF, Coebergh JW, van de Poll-Franse LV (2015) Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands. Ann Hematol 94(1):45–56CrossRefPubMed van den Broek EC, Oerlemans S, Nijziel MR, Posthuma EF, Coebergh JW, van de Poll-Franse LV (2015) Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands. Ann Hematol 94(1):45–56CrossRefPubMed
61.
Zurück zum Zitat Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, Bezares RF et al (2007) Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet 370(9583):230–239CrossRefPubMed Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, Bezares RF et al (2007) Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet 370(9583):230–239CrossRefPubMed
62.
Zurück zum Zitat Molica S (2006) Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma 47(8):1477–1480CrossRefPubMed Molica S (2006) Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma 47(8):1477–1480CrossRefPubMed
63.
Zurück zum Zitat Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C et al (2013) Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer 21(10):2853–2860CrossRefPubMed Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C et al (2013) Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer 21(10):2853–2860CrossRefPubMed
Metadaten
Titel
Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia
verfasst von
Eleshia J. Morrison
Joseph M. Flynn
Jeffrey Jones
John C. Byrd
Barbara L. Andersen
Publikationsdatum
19.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 12/2016
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2790-z

Weitere Artikel der Ausgabe 12/2016

Annals of Hematology 12/2016 Zur Ausgabe

ACKNOWLEDGEMENT TO REFEREES

Acknowledgement to referees

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.